High early mortality following percutaneous nephrostomy in metastatic cancer: a national analysis of outcomes.

ABSTRACT:

Objectives

To assess the outcomes of percutaneous nephrostomy in England for renal decompression, in the context of metastatic cancer.

Methods

Retrospective observational study of all patients undergoing nephrostomy with a diagnosis of metastatic cancer from 2010 to 2019 in England, identified and followed up within Hospital Episode Statistics.The primary outcome measure was mortality (14-day and 30-day postprocedure). Secondary outcomes included subsequent chemotherapy or surgery and direct complications of nephrostomy.

Results

10 932 patients were identified: 58.0% were male, 51.0% were >70 years old and 57.7% had no relevant comorbidities (according to Charlson's criteria, other than cancer).1 in 15 patients died within 14 days of nephrostomy and 1 in 6 died within

SUBMITTER: Dosanjh A 

PROVIDER: S-EPMC11672021 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature